Studies on the mechanism of fibrate-inhibited expression of plasminogen activator inhibitor-1 in cultured hepatocytes from cynomolgus monkey

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 1, 1997, Pages 26-32

  Arts, Janine ^a   Kockx, Maaìke ^a   Princen, Hans M G ^a   Kooistra, Teake ^a  

^a TNO   (Netherlands)

Author keywords

9 cis retinoic acid; fibrates; hepatocytes; peroxisome proliferator activated receptor; plasminogen activator inhibitor 1

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ALITRETINOIN; ANTILIPEMIC AGENT; EPIDERMAL GROWTH FACTOR; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; PEROXISOME PROLIFERATOR; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RETINOID X RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; HYPERLIPIDEMIA; LIVER CELL CULTURE; MONKEY; NONHUMAN; PRIORITY JOURNAL;

EID: 0031034317     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.1.26     Document Type: Article

References (29)

1. Schonfeld G. The effects of fibrates on lipoprotein and hemostatic coronary risk factors. Atherosclerosis. 1994;111:161-174.
2. Mussoni L, Mannucci L, Sirtori M, Camera M, Maderna P, Sironi L, Tremoli E. Hypertriglyccridemia and regulation of fibrinolytic activity. Arterioscler Thromb. 1992;12:19-27.
3. Andersen P, Smith P, Seljeflot I, Brataker S, Amesen H. Effects of gemfibrozil on lipids and haemostasis after myocardial infarction. Thromb Haemost. 1990;63:174-177.
4. Avellone G, Di Garbo V, Cordova R, Ranelli G, De Simone R, Bompiani G. Effect of gemfibrozil treatment on fibrinolysis system in patients with hypertriglyceridemia. Curr Ther Res. 1992;52:338-347.
5. Tenkanen L, Mänttäri M, Manninen V. Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Circulation. 1995;92:1779-1785.
6. Brown SL, Sobel BE, Fujii S. Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin: a potential link between lipid lowering and fibrinolysis. Circulation. 1995;92:767-772.
7. Keber I, Lavre J, Sue S, Keber D. The decrease of plasminogen activator inhibitor after normalization of triglycerides during treatment with fibrates. Fibrinolysis. 1994;8:57-59.
8. Fujii S, Sobel BE. Direct effects of gemfibrozil on the fibrinolytic system: diminution of synthesis of plasminogen activator inhibitor type I. Circulation. 1992;85:1888-1893.
9. Watanabe T, Okawa S, Itoga H, Imanaka T, Suga T. Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators. Biochim Biophys Acta. 1992; 1135:84-90.
10. Bien F. Peroxisome proliferators and cellular signalling pathways: a review. Biol Cell. 1993;77:43-46.
11. Bosnia PJ, Kooistra T. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells. J Biol Chem. 1991;266:17845-17849.
12. Orellana A, Holuigue L, Hidalgo PC, Faúndez V, González A, Bronfman M. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes. Ear J Biochem. 1993;215:903-906.
13. Lucore CL, Fujii S, Wun T-C, Sobel BE, Billadello JJ. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J Biol Chem. 1988;263: 15845-15848.
14. Westerhausen DR, Hopkins WE, Billadello JJ. Multiple transforming growth factor-β-inducible elements regulate expression of the plasminogen activator inhibitor type 1 gene in Hep G2 cells. J Biol Chem. 1991;266:1092-1100.
15. Auwerx J. Regulation of gene expression by fatty acids and fibric acid derivatives: an integrative role for peroxisome proliferator activated receptors. Horm Res. 1992;38:269-277.
16. Sakai M, Matsushimahibiya Y, Nishizawa M, Nishi S. Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between jun and peroxisome proliferator-activated receptor alpha. Cancer Res. 1995;55:5370-5376.
17. 16a. Arts J, Grimbergen J, Bosma PJ, Rahmsdorf HJ, Kooistra T. Role of c-Jun and proximal phorbol 12-myristate 13-acetate-(PMA)-responsive elements in the regulation of basal and PMA-stimulated plasminogen-activator inhibitor-1 gene expression in HepG2. Eur J Biochem. 1996;241:393-402.
18. Princen HMG, Huijsmans CMC, Kuipers F, Vonk RJ, Kempen HJM. Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7α-hydroxylase. J Clin Invest. 1986:78:1064-1071.
19. Kooistra T, Bosma PJ, Töns HAM, van den Berg AP, Meyer P, Princen HMG. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost. 1989:62:723-728.
20. Kaptein A, De Wit ECM, Princen HMG. Retinoids stimulate ApoA-I synthesis by induction of gene transcription in primary hepatocyte cultures from cynomolgus monkey (Macaca fascicularis). Arterioscler Thromb. 1993;13:1505-1514.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
23. Van den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, van Hinsbergh VWM. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb Haemost. 1988;60: 63-67.
24. Fort P, Many L, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase mulligenic family. Nucleic Acids Res. 1985;13:1431-1442.
25. Sher T, Yi H-F, McBride OW, Gonzalez FJ. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferates activated receptor. Biochemistry. 1993;32: 5598-5604.
26. Miyazawa S, Osumi T, Hashimoto T, Ohno K, Miura S, Fujiki Y. Peroxisome targeting signal of rat liver acyl-coenzyme A oxidase residues at the carboxy terminus. Mol Cell Biol. 1989;9:83-91.
27. Dodemont HJ, Soriano P, Quax WJ, Ramaekers F, Lenstra JA, Groenen MAM, Bernardi G, Bloemendal H. The genes coding for cytoskeletal proteins actin and vimentin in warm-blooded vertebrates. EMBO J. 1982;1:167-171.
28. Kooistra T, van den Berg J, Töns A, Platenburg G, Rijken DC, van den Berg E. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells. Biochem J. 1987; 247:605-612.
29. De Vries EGE, Meijer C, Timmer-Bosscha H, Berendsen HH, De Leij L, Scheper RJ, Mulder NH. Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up. Cancer Res. 1989;49:4175-4178.